Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NITEESH BHARARA

Allopathic & Osteopathic Physicians Pain Medicine Interventional Pain Medicine

NPI
1144480989
CMS profile
709644
Location
RESTON, VA

General Payments · PY2018–2024

$31,738.44

  • Reported across 231 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$553.79

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $553.79 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Nevro Corp. $227.58 3
Abbott Laboratories $133.61 4
ABBVIE INC. $108.33 4
PROTEGA PHARMACEUTIALS INC $47.15 1
Azurity Pharmaceuticals, Inc. $19.85 1
Medtronic, Inc. $17.27 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,698.12 23
PY2019 $15,145.79 36
PY2020 $2,377.06 27
PY2021 $1,245.54 45
PY2022 $1,275.41 43
PY2023 $1,442.73 43
PY2024 $553.79 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $3.24 03/13/2024 Food and Beverage Undisputed 01/23/2026 1124867798 CMS
Abbott Laboratories $7.72 09/16/2024 Food and Beverage Undisputed 01/23/2026 1124867800 CMS
Abbott Laboratories $9.76 10/22/2024 Food and Beverage Undisputed 01/23/2026 1124867802 CMS
Abbott Laboratories $112.89 11/08/2024 Food and Beverage Undisputed 01/23/2026 1124867804 CMS
ABBVIE INC. $26.34 01/29/2024 Food and Beverage Undisputed 01/23/2026 1103320730 CMS
ABBVIE INC. $21.49 04/10/2024 Food and Beverage Undisputed 01/23/2026 1103320732 CMS
ABBVIE INC. $33.20 07/25/2024 Food and Beverage Undisputed 01/23/2026 1103320734 CMS
ABBVIE INC. $27.30 08/22/2024 Food and Beverage Undisputed 01/23/2026 1103320736 CMS
Azurity Pharmaceuticals, Inc. $19.85 11/20/2024 Food and Beverage Undisputed 01/23/2026 1134003319 CMS
Medtronic, Inc. $17.27 12/19/2024 Food and Beverage Undisputed 01/23/2026 1117083297 CMS
Nevro Corp. $26.08 09/04/2024 Food and Beverage Undisputed 01/23/2026 1130786846 CMS
Nevro Corp. $155.00 09/11/2024 Food and Beverage Undisputed 01/23/2026 1130786848 CMS
Nevro Corp. $46.50 09/11/2024 Food and Beverage Undisputed 01/23/2026 1130786850 CMS
PROTEGA PHARMACEUTIALS INC $47.15 01/17/2024 Food and Beverage Undisputed 01/23/2026 1147553700 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.